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Abstract
Salmonella enterica infections are a significant global health issue, and development of vaccines against these bacteria
requires an improved understanding of how vaccination affects the growth and spread of the bacteria within the host. We
have combined in vivo tracking of molecularly tagged bacterial subpopulations with mathematical modelling to gain a
novel insight into how different classes of vaccines and branches of the immune response protect against secondary
Salmonella enterica infections of the mouse. We have found that a live Salmonella vaccine significantly reduced bacteraemia
during a secondary challenge and restrained inter-organ spread of the bacteria in the systemic organs. Further, fitting
mechanistic models to the data indicated that live vaccine immunisation enhanced both the bacterial killing in the very
early stages of the infection and bacteriostatic control over the first day post-challenge. T-cell immunity induced by this
vaccine is not necessary for the enhanced bacteriostasis but is required for subsequent bactericidal clearance of Salmonella
in the blood and tissues. Conversely, a non-living vaccine while able to enhance initial blood clearance and killing of virulent
secondary challenge bacteria, was unable to alter the subsequent bacterial growth rate in the systemic organs, did not
prevent the resurgence of extensive bacteraemia and failed to control the spread of the bacteria in the body.
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Introduction
Salmonella enterica causes systemic diseases (typhoid and
paratyphoid fever) [1], food-borne gastroenteritis and non-
typhoidal septicaemia (NTS) [2–4] in humans and in many other
animal species world-wide. Current measures to control S. enterica
infections are sub-optimal. The emergence of multi-drug resistant
strains has reduced the usefulness of many antibiotics [5–6].
Prevention of infection of food-production animals by implemen-
tation of biosecurity or hygiene measures is expensive and is
undermined by increased free-range production.
Vaccination remains the most feasible means to counteract S.
enterica infections. There is an urgent need for improved vaccines
against typhoid fever and there are currently no licensed
paratyphoid or NTS vaccines [7]. To attain a high level of
protective immunity against systemic infections with virulent
strains of Salmonella in susceptible hosts it is necessary to induce
both antibody responses and T-helper type 1 (TH1) cell-mediated
immunity [8]. This is due to the fact that intracellular control
requires TH1 immunity whereas antibodies can only target the
bacteria in the extracellular compartment (reviewed in [9–10]).
New generations of live attenuated vaccines have been
constructed in the last two decades and are currently being
evaluated in field trials. These vaccines mimic the course of
natural infection and are more protective than previous ones, but
we do not understand the mechanisms responsible for this [11–
12]. There is also a recent trend towards the development of non-
living vaccines against S. enterica enteric diseases for humans and
other animals. Current non-living vaccines are based on inacti-
vated whole cells and surface polysaccharides (e.g. Vi polysaccha-
ride and Vi conjugate vaccines for humans) [13–14] and subunit
protein-based vaccines are being considered. However, non-living
S. enterica vaccines vary greatly in their protective ability [15–19].
Vaccine design and selection is still largely an empirical process.
This is due to our insufficient understanding of how vaccine-
induced immune responses impact precisely on the dynamics of a
secondary infection in terms of bacterial division, killing, spread
and persistence in the tissues.
Interactions between infectious agents and their hosts occur in
diverse environments and over a range of scales: from initial
contact at the single cell level; spread throughout various
compartments of the host; and between hosts at a population
level. Intervention strategies to control infections can interfere with
the host-pathogen relationship at all these levels so understanding
the dynamics of infections at all scales is important. Mathematical
approaches have been extensively used to model infection
dynamics on the population level but until relatively recently
within-host dynamics have been measured rather crudely, typically
by monitoring total pathogen loads in a host or its organs. These
measures cannot disentangle the relative contributions of pathogen
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replication and death to overall growth. For example an
unchanging total pathogen load could be due to both replication
and killing occurring in balance, or to a lack of replication and no
killing. Attempts have been made to measure bacterial pathogen
division rates within hosts and cells by techniques such as using
non-replicating elements introduced into the bacteria, or dilution
of a fluorescent marker that is not expressed within the cell in vivo
[20–23] but these are often confounded by uncertainties concern-
ing the dynamics of these elements in complex in vivo milieu and
the potential effects on the phenotype of the pathogen being
investigated.
We have established and used a research approach based on the
tracking of bacterial subpopulations at multiple body sites to study
infections of mice and to capture the parameters that govern the
intra-organ and inter-organ infection processes. The system
employs simultaneous infections with individually identifiable
wild-type isogenic tagged strains (WITS) the relative proportions
of which can be determined by quantitative real-time PCR (qPCR)
[24–25] or other molecular techniques. One of the systems to
which this technology has been applied is the systemic phase of
experimental Salmonella infections in mice, a well-established
model for invasive disease [25]. In this system, observation of both
total bacterial loads and the changes in WITS population structure
enabled inference to be drawn on the rates of bacterial replication,
killing and spread between organs. This approach allowed us to
capture the key dynamic traits of the primary infection process in
unimmunised animals and to explore the impact of innate
immunity on the infection. In this previous study, we determined
that the infection process is multiphasic, with an initial phase of
rapid bacterial replication and killing of part of the inoculum by
the innate host response mediated by reactive oxygen species
(ROS), followed by a phase of growth and intra-organ spread with
the stochastic selection of individual bacterial subpopulations.
Later the infection moves to a phase in which bacteraemia and the
mixing of different subpopulations of bacteria in the organs occurs
[25].
In the present study we refined our framework and used it to
understand to what extent and at what stages of the infection
different vaccine types and different branches of the vaccine-
induced host immune response restrain intracellular division and
enhance bacterial killing, whether there are changes in the
patterns of local or systemic spread in vaccinated/immune
animals, whether immunity acts simultaneously or equally on
the global bacterial population, and whether there are intra- or
inter-organ differences and heterogeneous traits in the control of
individual bacterial subpopulations.
Results
Vaccination with live but not killed Salmonella restrains
both bacterial growth and inter-organ spread
Vaccination with either live or killed Salmonella is known to
increase the rate of blood clearance of an intravenous challenge,
result in a bias of segregation of bacteria towards the liver rather
than the spleen, and to enhance the reduction in bacterial loads in
the spleen and liver that occurs within the first hours [26–30]. To
investigate the contributions made by bacterial killing and growth
to these changes in total bacterial numbers we performed two
separate experiments vaccinating mice with either live attenuated
Salmonella Typhimurium (STm) SL3261 (Live Vaccine group:
LV) or acetone-killed STm SL1344 (Killed Vaccine group: KV).
Naive control and vaccinated animals (n= 9 or 10, see Table S1)
were then challenged with ,300 colony forming units (CFU) of
STm WITS and net bacterial numbers and WITS proportions
were monitored over a period of 72 h post-challenge (timepoints
30 min, 24, 48, 72 h). The challenge dose was chosen as the
minimum to yield reliable colonisation of both the liver and spleen
of vaccinated animals as determined in pilot experiments
described in the Methods section.
Vaccination with either type of vaccine resulted in accelerated
clearance of the WITS challenge inoculum from the blood with no
circulating bacteria detected at 30 min post-challenge (Figure 1).
In contrast the majority of naive animals still harboured bacteria
in the blood at this time. By 6 hr post-infection (p.i.) the majority
of vaccinated and non-vaccinated animals had cleared the
challenge dose from the blood and at 24 hr no bacteraemia was
observed in any of the mice tested.
At 24 h post-challenge, animals vaccinated with either
preparation had a lower bacterial load in the organs compared
to naive controls but the kinetics of this reduction differed
somewhat between vaccine types (Figure 1): at 6 h p.i. bacterial
loads in both organs of mice immunised with the LV were lower
than in the controls whereas for the KV loads were only
significantly lower in the spleen at this timepoint; by 24 h p.i.
bacterial loads in both vaccinated groups were lower than in the
controls. Subsequently between 24 and 72 h after challenge, mice
immunised with the KV and the unimmunised control mice both
allowed a rapid increase in bacterial numbers (,10-fold per day),
with no statistically significant difference between these groups,
and a resurgence of bacteraemia from 48 h p.i. In clear contrast,
net bacterial growth was much slower in the tissues of mice
vaccinated with live bacteria and bacteraemia was observed in
only one of nine mice tested and even then at a very low level;
Salmonella were absent from the spleens in 4/9 animals by 72 h
p.i.
Next we analysed the population structure of WITS in the
samples to determine when bacterial death and inter-organ spread
occurred. The challenge inoculum contained equal numbers of
each of 8 WITS. We first considered the number of distinct WITS
per mouse that were present in both organs (liver plus spleen), in
one organ only, or in neither of the organs (Figure 2). In the
absence of bacterial killing we would expect all individual WITS to
be represented in one or both organs. In contrast, if bacterial
killing was significant then the number of strains present in only
Author Summary
The bacterium Salmonella enterica causes gastroenteritis
and the severe systemic diseases typhoid, paratyphoid
fever and non-typhoidal septicaemia (NTS). Treatment of
systemic disease with antibiotics is becoming increasingly
difficult due to the acquisition of resistance. Licensed
vaccines are available for the prevention of typhoid, but
not paratyphoid fever or NTS. Vaccines can be either living
(attenuated strains) or non-living (e.g. inactivated whole
cells or surface polysaccharides) and these different classes
potentially activate different components of the host
immune system. Improvements in vaccine design require a
better understanding of how different vaccine types differ
in their ability to control a subsequent infection. We have
improved a previously developed experimental system
and mathematical model to investigate how these
different vaccine types act. We show that the inactivated
vaccine can only control bacterial numbers by a transient
increase in bactericidal activity whereas the living vaccine
is superior as it can induce an immune response that
rapidly kills, then restrains the growth and spread of
infecting bacteria.
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one organ, or absent from both would increase. Based on the
disappearance of WITS from either organ, we predicted that
bacterial death was higher during the first 24 h in animals
vaccinated with either vaccine compared to naive mice. In the
naive and KV groups, between 48 and 72 h p.i., we observed
increases in the numbers of individual WITS that were
simultaneously present in both spleen and liver (Figure 2). This
was suggestive of bacterial transfer between organs and coincided
temporally with detection of bacteraemia in these mice from the
48 hr time-point (Figure 1). The number of WITS that were
present or absent in the organs of mice immunised with the LV
remained approximately constant between 24 h and 72 h post-
challenge indicating that neither transfer between organs nor
substantial bacterial death had occurred in this group of animals.
In addition to determining the presence and absence of WITS
from the organs, we measured the proportion of each WITS
present in the spleen or liver (Figure 3). For the unvaccinated
animals at 30 min each WITS could be found in both the spleen
and liver with a proportion of approximately 1/8, i.e. the
population structure was similar to that in the inoculum (which
contained equal numbers of the eight WITS). By 6 h p.i. and until
the 24 h time-point, the population structures (i.e. presence,
absence and proportions of each WITS) in each organ of naive
mice had diverged (consistent with stochastic killing of bacteria
within the organs). By 48 h, coincident with the onset of
bacteraemia, the hepatic and splenic WITS population structures
became more similar – presumably due to transfer of bacteria
between the organs via the blood. Between 48 and 72 h p.i. the
liver and spleen populations became nearly homogenous within
each individual unvaccinated mouse (i.e. a given WITS was
present in the same proportion in the spleen and liver) (Figure 3;
Table 1).
Figure 1. Net growth of secondary challenge bacteria in mice immunised with living or killed vaccine. Live vaccine but not killed
vaccine controls bacterial loads following secondary challenge. Bacterial numbers (CFU) in the organs at the indicated times (h) post-challenge in
mice immunised with live vaccine (LV: green), killed vaccine (KV: blue) or naive controls (red). Dots show values in each mouse, boxes show the
quartiles for each group (25%, median and 75%). Challenge inoculum size doses were: LV experiment 243 CFU of WITS; KV experiment 280 CFU of
WITS. Significant differences in bacterial loads compared to naive controls are shown by: *P,0.05; **P,0.01; ***P,0.001 (Mann-Whitney U-test).
doi:10.1371/journal.ppat.1004359.g001
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For animals vaccinated with either LV or KV, there was a bias
in segregation of bacteria towards the liver, shown by compression
of the points around the vertical in Figure 3, and enhanced
bactericidal activity resulted in a number of WITS being absent
from one or both organs at 6 hr post-challenge. From 48 h the
WITS population structures in the KV and LV groups diverged:
the KV immunised animals showed a similar pattern to the
unvaccinated controls with highly correlated WITS organ
populations in all animals by 72 h (Figure 3; Table 1), and
with an increase in the number of WITS simultaneously present in
both the liver and spleen (Figure 2); in contrast, for the LV group
there was no increase in the co-occurrence of WITS in both
organs (Figure 2) and highly correlated WITS organ populations
were only observed in a minority of animals (Figure 3; Table 1),
therefore indicating that in most of these animals significant inter-
organ spread had not occurred up to 72 h post-challenge. The bias
in bacterial numbers towards the liver that was observed earlier in
the infection was still present in the LV group at this late
timepoint, presumably as a consequence of the restraint of both
bacterial growth and spread in this group resulting in populations
similar to the early timepoints. In contrast for the KV group this
bias had disappeared, likely a consequence of uncontrolled spread
and growth of bacteria in these animals.
Mathematical modelling and estimation of the rates of
bacterial killing and division in the spleen and liver
The enhanced reduction in total bacterial numbers, the
fluctuations in the WITS population structure and the disappear-
ance of WITS from the spleen and liver indicated that the overall
dynamics of bacterial division and death are different in naive
mice and in vaccinated animals in the early stages of the infection.
Bacterial dynamics were described using a stochastic model that
keeps track of the number of copies of a single WITS in the blood,
liver and spleen simultaneously [9,25]. The parameters of the
model (inoculum size, rates of bacterial replication, killing and
transfer from the blood to the organs) were all estimated by fitting
the model to the data from each experimental group at 0.5, 6 and
24 h post-inoculation, using maximum likelihood. In order to
allow for the possibility of early killing or inactivation of bacteria
before they start to colonise the organs, we estimated an effective
inoculum size consistent with the total number of bacteria 30 min
p.i. in each experimental group. By comparing these values with
the average inoculum doses actually used we obtained an estimate
of the fraction of bacteria eliminated in the very early stage of
infection (i.e. within 30 min of inoculation): this fraction was
highest (44%) in the LV group (Table 2). Biologically this could
be a consequence of bacterial killing and/or entry into a non-
replicative state [21,31–32]. In our model the remaining bacteria
settle into the liver and spleen where they undergo a process that
involves replication and killing. Comparing the model estimates
for these processes between groups (Table 2) we see that for both
vaccine types, the model captures the enhanced blood clearance
and increase in the proportion of bacteria going to the liver that
was observed in the data.
Estimates of the intra-organ replication and killing rates
(Figure 4) were very similar in naive mice and in mice immunised
with the LV in the first 6 h, whereas higher rates of bacterial
replication and killing in the liver were estimated in mice
immunized with the KV during this initial period of the secondary
infection, resulting in a more rapid net reduction in bacterial
numbers. All groups exhibited a large reduction in both the killing
and replication rates in the liver after 6 h, with replication rates
marginally higher than killing rates. The estimated killing and
replication rates were lower in the spleen than in the liver for the
first 6 h of the secondary infection, but became similar in both
organs between 6 and 24 h. In all cases, the fitted models
predicted distributions of bacterial loads and WITS abundancies
similar to the data (see Supporting Information Text S1)
Thus, based on variations in the population structure of WITS,
our model predicts that the reduction in the total numbers of
viable bacteria that is seen in the first 24 h in both groups of
immunised mice is largely due to enhanced bacterial killing in the
first few hours after challenge. More specifically, the models
predict that in mice immunised with the LV there was a
substantial reduction (by 44%) in the number of viable bacteria
compared to naive mice. This is predicted to occur before the
bacteria can be detected in the spleen and liver. The models
predict that once the bacteria are in the spleen and liver of the LV-
Figure 2. Co-occurrence of WITS in the livers and spleens during secondary challenge. LV-immunised animals show enhanced bactericidal
activity, bacteriostasis and reduced inter-organ transfer of bacteria as compared to naive controls. KV-immunised animals show only transient
enhancement of bactericidal activity. Each bar shows proportion of WITS present in both liver and spleen (purple), one organ only (dark pink) or
neither organ (light pink), pooled across mice within each experimental group at the indicated times (h) post-challenge. Top row: LV; Bottom row: KV;
Left column: Immunised animals; Right column: naive animals.
doi:10.1371/journal.ppat.1004359.g002
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Figure 3. Relative abundance of individual WITS in the spleens and livers. Secondary challenge bacteria segregate into the liver and spleen
to form independent populations within 6 h. Subsequently hepatic and splenic populations become homogeneous in naive and KV-immunised
animals but not in LV-immunised mice. All WITS within a mouse are represented by the same symbol. Points along the diagonal correspond to equal
abundances in both organs. Top two rows: mice immunised with live attenuated Salmonella vs naive controls (average challenge dose 243 CFU of
WITS); Bottom two rows: mice immunised with acetone-killed Salmonella vs naive controls (average challenge dose 280 CFU of WITS).
doi:10.1371/journal.ppat.1004359.g003
Table 1. Increase in correlation between organ bacterial populations over time.
% positive correlation
LV KV
Time p.i. (h) Naive Immunised Naive Immunised
0.5 0 11 0 0
6 0 0 10 10
24 0 0 11 11
48 50 11 56 60
72 100 25 100 100
Percentage of naive, LV or KV-immunised mice exhibiting a statistically significant positive correlation between the abundances of the WITS in the liver and spleen. This
was assessed by computing 95% confidence intervals for the coefficients of correlation (see Figure S7). Mice with bacteria absent from both liver and spleen were
excluded from the analysis.
doi:10.1371/journal.ppat.1004359.t001
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immunised mice they are subject to enhanced bactericidal activity
in the spleen and normal bactericidal activity in the liver as
compared to naı¨ve mice. For the KV, in contrast, we did not
observe any loss of viable bacteria by 30 min p.i., there was then
more intense bactericidal activity (combined with faster bacterial
replication) in the liver than any other group. Between 6 and 24 h
p.i. bacterial replication and killing rates decreased markedly in
animals immunized with either vaccine type showing that the
control of bacterial numbers after 6 h proceeds mainly by
bacteriostatic mechanisms.
Taken together the model estimates, measures of WITS co-
occurrence, and correlation between the organs show that
immunisation with KV enhances blood clearance, and increases
the killing rates in the organs (up to 24 h). Subsequently
bacteriostatic effects predominate, but these are not enhanced by
the killed vaccine over what is seen in naive animals, as shown by
similar increases over time in bacterial numbers in naive and KV
mice. In contrast, the immune response induced by the LV rapidly
inactivated (within 30 min) a large fraction of the challenge dose,
enhanced clearance of the bacteria from the blood and their
transfer into the organs and subsequently exerted a stronger
bacteriostatic effect which restrained bacterial growth more than
in naive or KV animals.
T-cells do not contribute to early LV-induced restraint of
bacterial growth but are important for late bacterial
killing
Animals immunised with a live vaccine can control the growth
of a secondary challenge in the spleen and liver. CD4+ and CD8+
T-cells are known to play a key role in immunity conferred by live
vaccination [8,33]. We therefore wished to determine how and at
which time T-cell dependent immune functions impact on the
dynamics of a secondary challenge in terms of control of bacterial
division, enhancement of death and restraint of spread between
systemic sites. LV-immunised mice were treated with either anti-
CD4 plus anti-CD8 antibodies, or with control immunoglobulins
two days before and after challenge with ,300 CFU of WITS.
Pilot experiments showed that differences in bacterial loads
Table 2. Maximum-likelihood estimates of model parameters for early events post-challenge.
Experiment Group % inoculum removed Clearance (h) %liver
A Naive 6 2.45 75
LV 44 0.32 86
B Naive 24 1.3 76
KV 10 0.34 93
Percentage of the inoculum removed; time taken for 99% of the remaining bacteria to be cleared from the blood into the organs; percentage of the inoculum that
segregated to the liver. LV: living vaccine; KV: killed vaccine.
doi:10.1371/journal.ppat.1004359.t002
Figure 4. Model estimates for rates of bacterial replication and killing. Rapid bacterial replication and killing is observed over the first 6 h
following re-challenge; between 6 and 24 h these rates decrease showing that bacteriostatic mechanisms predominate. Maximum likelihood
estimates with 95% confidence ellipses for the killing and replication rates of bacteria in the liver (left) and spleen (right) in each experimental group
for the periods 0–6 h (solid ellipses) and 6–24 h (dashed ellipses). The rates are expressed as 1og10(CFU) gained or lost per hour (for example, a killing
rate of 0.2 means that 37% of bacteria are killed within an hour). Diagonal grid lines indicate net growth rates (replication rate-killing rate).
doi:10.1371/journal.ppat.1004359.g004
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between T-cell positive and T-cell negative animals became
significant only by 72 h post-challenge therefore we extended the
time-course of the experiments to capture these differences; groups
of mice (n = 5 or 10, see Table S1) were sacrificed at 30 min, 6,
24, 48, 72, 96, 120 and 144 h and total bacterial numbers and
WITS population structures were assessed in the spleen, liver and
blood.
Depletion of T-cells had no effect on the bacterial loads of the
challenge organisms up to 48 h, but subsequently the groups
diverged with the LV immunised T-cell depleted animals having
higher loads and from 96 h bacterial numbers in this group were
increasing at a rate similar to that seen in naive animal (Figure 5).
Subsequently bacterial loads in T-cell depleted mice were
consistently higher than in LV-immunised control animals and a
resurgence of bacteraemia was detected in the T-cell depleted
mice. Bacterial counts in the control mice immunised with the LV
increased more slowly than in LV-immunised T-cell depleted
mice.
Observation of WITS co-occurrence in the spleens and livers
(Figure 6) showed similar overall bactericidal activity (absence of
individual WITS from both organs) up to 96 h post-challenge in
both control and T-cell depleted mice. Fitting the mathematical
model to this dataset showed that while estimated killing and
replication rates over the first 6 h were somewhat higher than in
the previously conducted LV experiment, there was little
difference between the T-cell depleted and control (T-cell
positive) mice (see Supporting Information Text S1). By 120 h,
the number of distinct WITS in the organs decreased in LV
immunised control mice, indicating killing of bacteria had started
to occur in LV. Conversely there was no evidence of bacterial
killing in T-cell depleted animals and the number of WITS
simultaneously present in both organs increased markedly from
72 h post-challenge which was also indicative of inter-organ
spread. The relative proportions of individual WITS in this group
were similar in the spleens and livers of T-cell depleted mice
(Figure 7; Table 3) confirming that inter-organ spread was
significant in these animals. A resurgence of bacteraemia was
observed at later time-points in vaccinated T-cell depleted
animals, this could not have been due to a defect in production
of antibody following T-cell depletion as there was no difference
in circulating Ig levels between T+ and T2 animals post-
secondary challenge (Figure S1). Unfortunately it was not
possible at this time to quantify these processes using our
mathematical model due to the increased complexity of the
system at later time points.
We also observed highly correlated WITS organ populations in
the majority of LV-immunised T-cell positive mice later in the
infection, but only from 120 h (Table 3) indicating that in these
mice bacteria were able to spread between organs despite the very
low-grade bacteraemia. By considering mice individually we see
that highly correlated populations were observed in those animals
with higher bacterial loads and that only one WITS made up the
majority of the population in these mice (Figure S2). T-cell
depleted animals also showed a limited number of WITS
predominating at 144 h although more individual WITS were
present in each sample presumably as bacterial killing was not
significant in these animals. KV-immunised mice showed the same
effect by 72 h post-challenge, as did naive mice albeit to a more
limited extent.
Taken together these data show that neither the LV-induced
initial rapid bacterial kill nor the subsequent bacteriostatic
mechanisms that predominate early in the infection were T-cell
dependent and that T-cell dependent bacterial killing became
observable by 120 h p.i.
Discussion
Here we show that previous immunisation with a live attenuated
Salmonella vaccine results in the rapid kill of a great proportion of
the challenge inoculum and additionally enhanced bacteriostasis
until the robust LV-induced T-cell response controls the infection
by bactericidal mechanisms. LV also controls secondary bacter-
aemia to extremely low levels and delays and reduces inter-organ
spread. Immunisation with a whole-cell killed vaccine enhanced
blood clearance and only transiently (within the first 24 h after
challenge) increased the rates of bacterial killing within the organs.
Later in the infection, the KV neither controlled the net growth of
the virulent challenge in the spleen and liver nor was able to
induce clearance of the bacteria from the tissues. The KV did not
control the rapid resurgence of bacteraemia and did not control
inter-organ spread despite its ability to induce anti-Salmonella
antibodies.
Mixed infections with individually identifiable wild-type isogenic
tagged strains (WITS) have recently been used to gather
information on the population dynamics of bacteria within hosts
[24–25,34]. Use of multiple isogenic strains facilitates more refined
measurement of subpopulations than using a more limited number
of strains selectable with different antibiotics [35–37] as well as
limiting the possibility of phenotypic variation between competing
strains with different genotypes.
In this study we used WITS to study the in vivo population
dynamics of S. Typhimurium during secondary challenge
following vaccination. In the early phase of the challenge (up to
24 h) we estimated bacterial replication and killing rates by
mathematical modelling. For later stages in the infection we could
infer the times at which inter-organ spread and bacterial killing
became observable by tracking the presence or absence of WITS
in the organs and calculating the correlation between the
abundances of WITS in the organs. We chose the parenteral
route to investigate the secondary challenge dynamics in mice
immunised with either a killed vaccine or a live attenuated strain.
This route enabled us to study specifically the dynamics that
underpin control of the bacteria in the systemic compartment.
Systemic control of the infection - in other words the suppression
of bacterial growth, restraint of dissemination in the spleen, liver
and blood, and clearance of the bacteria from the tissues - is an
absolute requirement for both host survival in systemic Salmonella
infections and for the successful elimination of the infection. We
used secondary challenge inoculum sizes of ,300 CFU as the
lowest dose that consistently prevented rapid clearance in
immunised animals. This dose is similar to a recent estimate of a
rate of migration of 298 CFU/day of STm from the gastrointes-
tinal tract into the cecal lymph node following oral infection of
mice [34].
We used a host-pathogen combination where a virulent strain
was injected as the challenge organism into innately susceptible
mice. This stringent combination always results in lethal infections
in naı¨ve animals. Bacterial numbers initially decline following
challenge due to reactive oxygen radical mediated killing which
exceeds division, but subsequently killing becomes negligible and
intracellular replication results in a constant and exponential
increase in bacterial numbers in the spleen and liver until death of
the animal [25]. In this stringent model we showed that the LV
induces an immune response that controls a secondary infection in
four phases: rapid clearance of bacteria from the blood into the
organs coupled with an initial very rapid (within 30 min)
inactivation of a large fraction of the challenge dose; a period
(,6 h) of relatively rapid bacterial replication and killing
essentially equivalent to that in naive animals; a T-cell indepen-
Salmonella Infection Dynamics in Vaccinees
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dent bacteriostatic phase that lasts for about three days and
restrains bacterial growth more than in naive controls; and a
subsequent phase in which T-cell dependent bacterial killing
becomes significant. Assessment of net bacterial numbers alone
would not have distinguished the time of transition between these
latter two phases as total bacterial loads were relatively stable over
the time period under investigation. The very rapid initial
inactivation of the challenge could be a consequence of bacterial
killing, or entry into a non-replicative state [21,31–32] that cannot
be recovered from following direct plating of organ homogenates.
Any early bacterial killing is unlikely to be the result of serum
bactericidal activity as mouse serum lacks such activity against
Salmonella due to a reduced ability to deposit C3 [38–39]. We
confirmed this experimentally by assessing the survival of S.
Typhimurium SL1344 in serum collected from mice immunised
with the LV (Figure S3). Entry into a non-replicative state is also
unlikely to account for the large drop in viable bacterial numbers
seen as non-replicating salmonellae have not been observed at
high levels in the spleen, and resume growth upon culturing [40].
We showed that the whole-cell killed vaccine did not induce the
very rapid inactivation of the challenge dose seen in mice
immunised with the LV, but did result in a decrease in total
bacterial loads as compared to naive controls by 6 h post-
challenge. This was primarily due to rapid blood clearance leading
to more time being available for bactericidal mechanisms to exert
their effect coupled with an increase in killing rate in the liver.
While it has been known for many years that living and non-living
vaccines can reduce total bacterial loads within the first hours of a
re-infection [26–30] it is now clear that these reductions proceed
with markedly different kinetics. After the first 24 h for animals
immunised with the KV there was no additional restraint of
bacterial growth, enhancement of killing or control of bacteraemia
Figure 5. Net growth of secondary challenge bacteria in LV-immunised mice depleted of T-cells as compared to controls. T-cell
depleted mice fail to restrain growth of secondary challenge bacteria from 72 h p.i. Bacterial numbers (CFU) in the organs of live-vaccine immunised
mice at the indicated times post-challenge with 310 CFU WITS. Mice were controls (T+: green) or depleted of T-cells (T2:red). Dots show values in
each mouse, boxes show the quartiles for each group (25%, median and 75%). Significant differences in bacterial loads between T+ and T2 mice are
shown by: *P,0.05; **P,0.01; ***P,0.001 (Mann-Whitney U-test).
doi:10.1371/journal.ppat.1004359.g005
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and the infection proceeded as in naive animals despite the
presence of circulating antibodies. We also saw a decrease in the
number of WITS absent simultaneously from both livers and
spleens at later time-points in KV-immunised animals. This could
have been due to re-emergence of bacteria from sites that we did
not sample in this study, for example the bone marrow, during the
haematogenous spread phase of the infection. This phenomenon
was not observed in LV-immunised animals.
Vaccination with live attenuated Salmonella is known to induce
higher levels of IgG2a (IgG2c in C57BL/6 mice) as compared to a
killed vaccine [16], which we also confirmed in our model (Figure
S4). Opsonisation of Salmonella with immune serum increases
both the uptake of bacteria by macrophages and bacterial killing
via the production of reactive oxygen intermediates (ROI) by the
phagocyte NADPH oxidase (phox) [41]. phox also possesses
bacteriostatic functions [42], which we showed were important
in naive animals in vivo after its initial bactericidal effect [25].
Macrophage uptake of IgG-opsonised Salmonella is primarily
mediated by FccRI which binds IgG2c [41]. It is therefore possible
that both the LV-induced immediate bacterial killing and
extended bacteriostasis are due in part to enhanced production
of anti-Salmonella IgG2c. Reactive nitrogen intermediates (RNI),
produced by iNOS, are also known to have bacteriostatic activity
both in vitro and in vivo [43–44] and while opsonisation has not
been reported to increase RNI production by macrophages in
vitro [41] it is possible that such an effect does occur in vivo.
In this study we observed that the bacterial population
structures in naive mice, and in KV and LV-immunised mice
eventually become homogeneous between the livers and spleens
indicating that inter-organ mixing of WITS occurs during the
infection process. However, mixing occurs earlier in naive mice, in
mice immunised with the KV and in LV-immunised T-cell
depleted animals compared to control LV-immunised wild-type
mice. This inter-organ mixing coincided with bacteria becoming
detectable in the blood suggesting that haematogenous spread is
responsible for transfer of bacteria between organs. In the majority
of the LV-immunised mice inter-organ mixing was seen in the
absence of detectable bacteraemia which leads us to speculate that
in these animals very few bacteria are released into the blood at
any time due to a more efficient control of bacterial release from
the infection foci.
In the KV-vaccinated mice, as the secondary infection
progressed a small number of individual WITS predominated
within the overall population structure. This phenomenon was also
Figure 6. Co-occurrence of WITS in the livers and spleens during secondary challenge. T-cell dependent bactericidal activity is evident in
LV-immunised mice by 120 h post-rechallenge; depletion of T-cells from LV-immunised animals results in inter-organ spread of bacteria from 72 h.
Each bar shows the distribution of all WITS in each experimental group at the indicated time post-challenge. From bottom up: proportion of WITS
present in both liver and spleen (purple); in one organ only (dark pink); in neither organ (light pink).
doi:10.1371/journal.ppat.1004359.g006
Figure 7. Relative abundance of individual WITS in the spleens and livers. Secondary challenge bacteria segregate into the liver and spleen
to form independent populations within 6 h. Subsequently hepatic and splenic populations become homogeneous from 120 h. All WITS within a
mouse are represented by the same symbol. Points along the diagonal correspond to equal abundances in both organs. Mice were either controls or
depleted of T-cells (T2); they all received the live vaccine and were challenged with 310 CFU of WITS.
doi:10.1371/journal.ppat.1004359.g007
Salmonella Infection Dynamics in Vaccinees
PLOS Pathogens | www.plospathogens.org 9 September 2014 | Volume 10 | Issue 9 | e1004359
observed in naive control mice in this study although to a lesser
extent than was previously seen when naive animals were
challenged with a lower dose (,90 CFU) [45]. Given that we do
not observe bacterial killing during the net growth phase of WITS
in the tissues in these mice (from 24 h p.i. onwards), the increased
prevalence of some WITS is likely to be due to a relatively faster
expansion of some WITS populations over others within each
organ. Salmonella adapt in vivo to enter a state in which net intra-
organ growth is faster [10] and individual foci of infection arise
from distinct clonal populations [46]. We speculate that the
expansion of a limited number of WITS populations is a
consequence of a loss of control of the infection at a small number
of foci (each of which contains a single WITS) resulting in release
of bacteria that then establish secondary foci with rapidly growing
bacteria [9,25,47–48].
A similar prevalence of a low number of distinct WITS was also
seen in the later stages of the secondary infection in mice
immunised with LV suggesting that loss of focal control at a
limited number of sites also occurs in these animals. However in
these mice we observed a T-cell dependent bactericidal activity of
the immune system from 120 h onwards and therefore it is
possible that bacterial killing is also responsible for the stochastic
prevalence of some bacterial subpopulations over others.
Overall our study indicates the superiority of a live attenuated
vaccine over a whole-cell killed one in controlling the infection
process by suppressing bacterial growth, exerting bacterial killing and
achieving clearance of the inoculum from the tissues. The latter
function is ascribable to the T-cell response induced by the LV since it
can be abrogated by depletion of T-cells before challenge. This work
indicates that a KV is inadequate to control a secondary infection in a
very stringent host pathogen combination. New generations of
Salmonella vaccines such as polysaccharide and subunit vaccines for
typhoid and NTS are currently being considered and empirically
tested. These preparations rely on the induction of antibodies for their
protective activity so the optimisation of these vaccines and their
delivery would benefit from improvements in their ability to induce
T-cell mediated immunity.
Materials and Methods
Bacterial strains, media and growth conditions
S. enterica serovar Typhimurium (STm) WITS strains 1, 2, 11,
13, 17, 19, 20 and 21 which have been described previously [25]
were made by inserting 40 bp signature tags and a kanamycin
resistance cassette between the malXY pseudogenes of STm
JH3016 [49], a gfp+ derivative of wild-type virulent SL1344. They
are phenotypically wild-type for growth in broth and infectivity for
mice. The live attenuated STm SL3261 aroA [50] strain was used
for all immunizations. Bacteria for infection were grown for 16 h
at 37uC in L-broth (LB) without aeration and diluted in
phosphate-buffered saline (PBS) prior to inoculation. Enumeration
of bacteria was by plating dilutions on LB agar plates.
Ethics statement
All experiments involving animals were conducted under
project licences approved by the University of Cambridge Animal
Welfare and Ethical Review Body, granted by the United
Kingdom Home Office (licence numbers PPL 80/2135 and PPL
80/2572), and performed in observance of licensed procedures
under the United Kingdom Animals (Scientific Procedures) Act
1986.
Immunization and infections
Female age-matched C57BL/6 mice were purchase from
Harlan Laboratories and used when over 9 weeks of age. Live
bacteria for parenteral immunization were prepared from a 16 hr
static culture of STm SL3261, diluted 1/100 in PBS and
administered by i.v. injection into the tail vein in 200 ml aliquots
(,106 CFU/mouse). Actual inoculum dose was determined by
plating dilutions. We confirmed that this immunisation regime
elicited anti-Salmonella antibodies (Figure S1) and elicited a
TH1-type memory response (Figure S5). Challenge with WITS
was performed three months after immunisation with the LV by
which time the primary infection was cleared, as determined by
sampling livers and spleens of mice in pilot experiments (n= 2),
and demonstrated previously [51].
Acetone killed wild-type bacteria for immunization were
prepared as previously described [16]. Briefly, bacteria from a
100 ml culture of STm SL1344 grown for 16 h at 37uC with
aeration in tryptic soy broth (Oxoid) were harvested by
centrifugation at 3220 g, resuspended in 100 ml PBS and viable
counts determined by plating. Following three sequential washes
in acetone, bacteria were harvested, acetone completely removed
by evaporation, cells resuspended in PBS to an equivalent
concentration of 561010 CFU/ml and stored in aliquots at 2
20uC or below. Immunization was by administration of two doses
Table 3. Increase in correlation between organ bacterial populations over time.
% positive correlation









Percentage of T-cell depleted (T2) or T-cell positive (T+) live-vaccine immunised mice exhibiting a statistically significant positive correlation between the abundances
of the WITS in the liver and spleen. This was assessed by computing 95% confidence intervals for the coefficients of correlation (Figure S8). Mice with bacteria absent
from both liver and spleen were excluded from the analysis.
doi:10.1371/journal.ppat.1004359.t003
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of 108 cells given subcutaneously in the back, 3-weeks apart. The
subcutaneous route was chosen as in our experience this results in
a strong antibody response with the killed vaccine whereas i.v.
immunisation does not. Regardless of route the KV is known to be
unable to induce protective T-cell immunity against virulent
challenge. We confirmed that this immunisation regime elicited
anti-Salmonella antibody, although there was a somewhat lower
production of IgG as compared to immunisation with the LV, due
to a decrease in levels of IgG2c (Figure S4). Challenge with
WITS was performed 6 weeks post-primary immunisation.
For T-cell depletion experiments 500 mg each of rat IgG2b anti-
mouse CD4 and anti-mouse CD8 (prepared by Harlan Bioprod-
ucts from hybridomas YTS 191.1 and YTS 169.4.2 respectively.
Hybridoma lines were a kind gift of Prof. Anne Cooke, University
of Cambridge) in PBS were injected into the tail vein at days 22
and +2 with respect to the challenge [33,52–53]. Control animals
received normal rat globulins (mpBiomedical). In this model the
development of immunity post-vaccination proceeds normally as
the mice are wild-type; removal of T-cells only occurs around the
time of challenge. This regime was confirmed by FACS to deplete
the mice of both CD4+ and CD8+ splenocytes (Figure S6).
For infections with WITS, each strain was individually grown
statically for 16 h in L-broth and aliquots mixed to obtain a stock
with each strain in an equal amount. Bacteria from 1 ml of this
stock were harvested by centrifugation for subsequent qPCR.
Dilutions of the stock were then made in PBS (typically 1 in
56105) to achieve the desired final cell density for i.v. injection of
200 ml doses into the tail vein. Actual cell density of the inoculums
were determined by plating triplicate 200 ml aliquots, cell density
in the individual WITS cultures was also determined. Experimen-
tal group sizes are shown in Table S1.
To enable mathematical modelling of subpopulation structures
we attempted to determine a single challenge dose that would
result both in consistent colonisation of the organs in immunised
animals, and a frequency of WITS absence in naive animals that
would enable paramaterisation of our previously developed model;
in naive animals a dose of ,90 CFU is appropriate [25]. We
conducted pilot experiments where animals immunised with the
LV or naive controls were challenged with 90, 300, 900 or
9000 CFU total WITS and we determined the WITS population
structure in spleens and livers at 6 h post-infection (Table S2)
when bacterial counts are at a minimum in naive animals [25]. At
the lowest dose there was excessive WITS loss in the spleen of
immunised animals while at the other doses there was insufficient
loss of WITS from naive animals. We therefore selected a
challenge dose of ,300 CFU which consistently resulted in
colonisation of the spleen in immunised animals and modified the
mathematical models to account for variations in the relative
proportions of WITS between animals, rather than merely for the
presence or absence of subpopulations.
Enumeration and recovery of viable Salmonella in blood
and tissues
Blood was obtained from the tail vein in heparin-coated tubes,
mice were humanely killed by cervical dislocation, spleens and
livers removed and individually homogenised in a Stomacher80
(Seward) with 5 ml distilled water. If required, dilutions were made
to enable enumeration by pour plating 100 ml aliquots in 6-well
plates. Entire blood samples or tissue homogenates in 1 ml
aliquots were inoculated onto the surface of 90 mm agar plates.
Following overnight incubation at 37uC, colonies were enumer-
ated and total bacteria harvested from the plates by washing with
2 ml PBS. Bacteria were thoroughly mixed by vortexing,
harvested by centrifugation and stored at 280uC prior to DNA
extraction.
Determination of WITS proportions in bacterial samples
by qPCR
DNA was prepared from aliquots of bacterial samples
(typically ,56109 CFU) using a DNeasy Blood and Tissue kit
(QIAGEN). DNA concentration was determined using a
NanoDrop 1000 spectrophotometer (Thermo Scientific). Ap-
proximately 106 total genome copies were analysed for the
relative proportions of each WITS by qPCR on a Rotor-Gene
Q (QIAGEN). Duplicate reactions were performed for each
sample with primer pairs specific for each WITS in separate
20 ml reactions (primers in Table S3). Each reaction contained
10 ml QuantiTect SYBR Green (QIAGEN), 1 mM each primer,
4 ml sample and DNase-free water to 20 ml. Thermal cycling
was 95uC for 15 min; 35 cycles of 94uC for 15 s, 61uC for 30 s,
and 72uC for 20 s. The copy number of each WITS genome in
the sample was determined by reference to standard curves for
each primer pair. Standard curves were generated for each
batch of PCR reagents by performing qPCRs in duplicate on 4
separate dilution series of known concentrations of WITS
genomic DNA.
Mathematical model and statistical inference
We used a branching process model that kept track of the
distribution of the number of bacteria of a single WITS in three
compartments: blood, liver and spleen. The model is outlined
here, a full description is in Supporting Information Text S1.
While we had determined the average number of CFU in the
inoculum by plating, total bacterial loads in the LV immunized
animals at 30 min were markedly lower, presumably due to the
rapid activity of bactericidal mechanisms. In order to account
for this observation we assumed that at time t = 0, the bacteria
followed a Poisson distribution with unknown mean n in the
blood, whence they migrate into the liver (at rate cL) and the
spleen (at rate cS). Upon entering the liver, bacteria replicate at
rate rL and are killed at rate kL. Likewise, those in the spleen
replicate at rate rS and are killed at rate kS. For the sake of
parsimony, we assume that these rates remain constant for the
first six hours, and we estimate them by fitting the model to the
data from first two time points (0.5 h and 6 h post inoculation).
We then allow the replication and killing rates to change at
t = 6 h and assume they remain constant until t= 24 h; we
estimate these new values by fitting the model to the data from
the third time point (24 h p.i.). For each experimental
treatment, we thus estimate 11 parameters (n, cL, cS, kL1, kS1,
rL1, rS1, kL2, kS2, rL2, rS2) from up to 720 data points (3 time
points 69 or 10 mice 63 compartments 68 strains), where
subscripts 1 and 2 refer to the two time intervals considered (0–
6 h and 6–24 h respectively) We assumed that all strains and all
mice were independent and shared identical parameters within
each experimental group. Our model did not allow movement
of bacteria from the liver or the spleen back into the blood, as
data strongly suggested that this does not happen until after
24 h [25].
Inference was done by maximum likelihood; the complete
mathematical formulation is presented in Supporting Information
Text S1. Basically, for a given set of model parameters, we
computed the joint probability distribution of the number of copies
of a single WITS in the blood, liver and spleen during the first
24 h by solving the master equations of the branching process. In
order to compute the likelihood of the model, we also needed to
determine the probability of observing a set of data (CFU and
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proportions of the 8 WITS in the blood, liver and spleen from a
given mouse) given the unobserved numbers of copies of each
WITS that were actually present in the blood and organs of that
mouse (which correspond to the variables in our stochastic model);
in other words, we had to estimate the noise generated by the
experimental procedure. This was achieved by an additional
calibration experiment: we plated known numbers of each WITS,
harvested the colonies and processed known combinations of the
eight WITS by qPCR. We then performed regressions of the
observed proportions of the WITS by qPCR against the known
numbers of colonies. We compared six models by AIC (Akaike’s
Information Criterion) for the distribution of v (the product of the
total number of colonies harvested by the proportion of a single
WITS reported by qPCR) given n (the actual number of colonies
of this particular WITS on the plate). The most parsimonious was
a log-normal distribution where the log-standard-deviation
decreases exponentially with n, namely: log(v),N(log(-
n),0.267e20.0148n). See Supporting Information Text S1 for
further detail. All the analyses were performed in R version 3.0
[54], and likelihood estimation was done using the R library
Powell [55].
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